BAFF促进慢性移植物抗宿主病中B细胞受体反应性增强
研究探讨BAFF在异基因骨髓移植后慢性移植物抗宿主病(cGVHD)中的作用。在MHC错配小鼠模型中,cGVHD伴随BAFF水平升高、BAFF/B细胞比值增高及BCR活化B细胞持续存在;BAFF通过上调B细胞NOTCH2和SYK蛋白增强BCR反应性,并促进cGVHD表现及同种抗体产生。
要点
- cGVHD小鼠BAFF升高并非仅反映B细胞数量减少,受体成纤维网状细胞和供体CD4+ T细胞也增加BAFF转录。
- BAFF通过上调B细胞NOTCH2和SYK蛋白增强BCR反应性,高BAFF/B细胞比值与BCR活化B细胞持续存在相关。
- BAFF转基因供体细胞促进cGVHD表现、循环GL7+ B细胞和同种抗体产生,提示靶向BAFF/BCR通路值得研究。
核心结论
- 病理性BAFF产生促进B细胞区室改变并增强BCR反应性,从而推动cGVHD表现。
- 研究结果支持在cGVHD患者中开展靶向BAFF和BCR通路的治疗研究。
研究设计与样本
- 采用主要组织相容性复合体错配的cGVHD样表现小鼠模型,包括B淋巴细胞缺陷的μMT异基因骨髓移植受体。
- 使用BAFF转基因小鼠供体细胞(包括去除T细胞的仅骨髓供体)探讨高BAFF对BCR活化和cGVHD表现的影响。
主要发现
- cGVHD小鼠BAFF水平升高并非仅反映B细胞数量,后来发生cGVHD的小鼠受体成纤维网状细胞数量显著增加且BAFF转录水平更高。
- 患病小鼠和患者的CD4+ T细胞中BAFF转录增加,提示供体细胞BAFF产生也可能贡献于cGVHD。
- 小鼠cGVHD表现与高BAFF/B细胞比值及外周血和病变组织中BCR活化B细胞持续存在相关。
- BAFF上调B细胞NOTCH2表达,增强对替代抗原和NOTCH配体的BCR反应性;BAFF转基因B细胞中近端BCR信号分子SYK蛋白水平显著增加,且BAFF在体外BCR活化后或体内存在同种抗原时维持高SYK蛋白。
- 使用去除T细胞的BAFF转基因供体(仅骨髓)发现BAFF促进cGVHD表现、循环GL7+ B细胞和同种抗体产生。
临床怎么用
- 在cGVHD患者中可关注BAFF/B细胞比值及BCR活化B细胞,作为疾病活动相关指标。
- BAFF和BCR通路可能成为cGVHD的潜在治疗靶点,但需进一步临床研究验证。
局限性
- 主要证据来自小鼠模型,人体cGVHD中的BAFF/BCR通路作用尚需临床研究验证。
- 原文未报告具体样本量、P值或效应量等定量数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Patients with chronic graft-versus-host disease (cGVHD) have increased B cell-activating factor (BAFF) levels, but whether BAFF promotes disease after allogeneic bone marrow transplantation (allo-BMT) remains unknown. In a major histocompatibility complex-mismatched model with cGVHD-like manifestations, we first examined B-lymphopenic μMT allo-BMT recipients and found that increased BAFF levels in cGVHD mice were not merely a reflection of B-cell number. Mice that later developed cGVHD had significantly increased numbers of recipient fibroblastic reticular cells with higher BAFF transcript levels. Increased BAFF production by donor cells also likely contributed to cGVHD, because BAFF transcript in CD4+ T cells from diseased mice and patients was increased. cGVHD manifestations in mice were associated with high BAFF/B-cell ratios and persistence of B-cell receptor (BCR)-activated B cells in peripheral blood and lesional tissue. By employing BAFF transgenic (Tg) mice donor cells, we addressed whether high BAFF contributed to BCR activation in cGVHD. BAFF increased NOTCH2 expression on B cells, augmenting BCR responsiveness to surrogate antigen and NOTCH ligand. BAFF Tg B cells had significantly increased protein levels of the proximal BCR signaling molecule SYK, and high SYK protein was maintained by BAFF after in vitro BCR activation or when alloantigen was present in vivo. Using T cell-depleted (BM only) BAFF Tg donors, we found that BAFF promoted cGVHD manifestations, circulating GL7+ B cells, and alloantibody production. We demonstrate that pathologic production of BAFF promotes an altered B-cell compartment and augments BCR responsiveness. Our findings compel studies of therapeutic targeting of BAFF and BCR pathways in patients with cGVHD.
引用
- Jia W, Poe JC, Su H, et al. BAFF promotes heightened BCR responsiveness and manifestations of chronic GVHD after allogeneic stem cell transplantation. Blood. 2021. PMID: 33534893. doi:10.1182/blood.2020008040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。